학술논문

Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trials
Document Type
article
Source
Spinal Cord. 56(5)
Subject
Allied Health and Rehabilitation Science
Biomedical and Clinical Sciences
Clinical Sciences
Health Sciences
Spinal Cord Injury
Clinical Research
Traumatic Head and Spine Injury
Neurodegenerative
Neurosciences
Physical Injury - Accidents and Adverse Effects
Clinical Trials and Supportive Activities
Neurological
Good Health and Well Being
Clinical Trials as Topic
Humans
Outcome Assessment
Health Care
Spinal Cord Injuries
Human Movement and Sports Sciences
Rehabilitation
Allied health and rehabilitation science
Language
Abstract
Study designThis is a focused review article.ObjectivesThis review presents important features of clinical outcomes assessments (COAs) in human spinal cord injury research. Considerations for COAs by trial phase and International Classification of Functioning, Disability and Health are presented as well as strengths and recommendations for upper extremity COAs for research. Clinical trial tools and designs to address recruitment challenges are identified.MethodsThe methods include a summary of topics discussed during a two-day workshop, conceptual discussion of upper extremity COAs and additional focused literature review.ResultsCOAs must be appropriate to trial phase and particularly in mid-late-phase trials, should reflect recovery vs. compensation, as well as being clinically meaningful. The impact and extent of upper vs. lower motoneuron disease should be considered, as this may affect how an individual may respond to a given therapeutic. For trials with broad inclusion criteria, the content of COAs should cover all severities and levels of SCI. Specific measures to assess upper extremity function as well as more comprehensive COAs are under development. In addition to appropriate use of COAs, methods to increase recruitment, such as adaptive trial designs and prognostic modeling to prospectively stratify heterogeneous populations into appropriate cohorts should be considered.ConclusionsWith an increasing number of clinical trials focusing on improving upper extremity function, it is essential to consider a range of factors when choosing a COA.SponsorsCraig H. Neilsen Foundation, Spinal Cord Outcomes Partnership Endeavor.